David S Morgan
Overview
Explore the profile of David S Morgan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montoya M, Harmsen H, Baer B, Long N, Messimore A, Jayani R, et al.
Bone Marrow Transplant
. 2024 Sep;
59(12):1780-1782.
PMID: 39256585
No abstract available.
2.
Bowers E, Martin E, Jarabek A, Morgan D, Smith H, Dailey L, et al.
Toxicol Sci
. 2021 Oct;
185(1):38-49.
PMID: 34718810
Inhaled chemical/material exposures are a ubiquitous part of daily life around the world. There is a need to evaluate potential adverse effects of both single and repeat exposures for thousands...
3.
Diefenbach C, Hong F, Ambinder R, Cohen J, Robertson M, David K, et al.
Lancet Haematol
. 2020 Aug;
7(9):e660-e670.
PMID: 32853585
Background: Recognising that the immune suppressive microenvironment promotes tumour growth in Hodgkin lymphoma, we hypothesised that activating immunity might augment the activity of targeted chemotherapy. We evaluated the safety and...
4.
Goy A, Ramchandren R, Ghosh N, Munoz J, Morgan D, Dang N, et al.
Blood
. 2019 Jul;
134(13):1024-1036.
PMID: 31331917
The outcome of patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) is poor, particularly in patients ineligible for stem cell transplantation or who fail induction therapy or salvage therapy. The...
5.
Sethi T, Kovach A, Grover N, Huang L, Lee L, Rubinstein S, et al.
Leuk Lymphoma
. 2019 Jun;
60(12):2880-2889.
PMID: 31184237
Primary central nervous system lymphoma (PCNSL) patients have a poorer prognosis than systemic lymphoma. Gain-of-function c.794T > C (p. L265P) mutation and programed cell death-1 (PD-1) pathway alterations are potential...
6.
Zavala J, Ledbetter A, Morgan D, Dailey L, Puckett E, McCullough S, et al.
Inhal Toxicol
. 2018 Aug;
30(4-5):169-177.
PMID: 30086657
A cell culture exposure system (CCES) was developed to expose cells established at an air-liquid interface (ALI) to volatile chemicals. We characterized the CCES by exposing indigo dye-impregnated filter inserts...
7.
Bowers E, McCullough S, Morgan D, Dailey L, Diaz-Sanchez D
Sci Rep
. 2018 Jun;
8(1):9398.
PMID: 29925859
Inter-individual variability is observed in all biological responses; however this variability is difficult to model and its underlying mechanisms are often poorly understood. This issue currently impedes understanding the health...
8.
Nguyen V, Pophali P, Tsai J, Jagadeesh D, Dean R, Pohlman B, et al.
Br J Haematol
. 2016 Jul;
179(4):674-676.
PMID: 27409578
No abstract available.
9.
McCullough S, Bowers E, On D, Morgan D, Dailey L, Hines R, et al.
Toxicol Sci
. 2016 Jan;
150(1):216-24.
PMID: 26719369
Traditional toxicological paradigms have relied on factors such as age, genotype, and disease status to explain variability in responsiveness to toxicant exposure; however, these are neither sufficient to faithfully identify...
10.
Simpson D, Lemonie N, Morgan D, Gaddameedhi S, Kaufmann W
Cancers (Basel)
. 2015 Jun;
7(2):1072-90.
PMID: 26091525
The oncogenic BRAF(V600E) mutation is common in melanomas as well as moles. The roles that this mutation plays in the early events in the development of melanoma are poorly understood....